Paper
8 January 2024 Role of LIF and LIFR in colorectal cancer
Qian Ma
Author Affiliations +
Proceedings Volume 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023); 1292406 (2024) https://doi.org/10.1117/12.3012845
Event: 3rd International Conference on Biological Engineering and Medical Science (ICBioMed2023), 2023, ONLINE, United Kingdom
Abstract
In 2020, colorectal cancer has become the third worldwide most prevalent cancer and second deadliest cancer and its prevalence rate is still on the rise. IL-6 cytokine superfamily includes a group of cytokines that are crucial factors in the development of tumors. Leukemia inhibitory factor belongs to this superfamily, showing its activity in regulating different kinds of signal transduction pathways and helping inhibit differentiation and regeneration of stem cells, involved in immune procession and inflammation. LIF also exercises an influence over a variety of cancers. Leukemia inhibitory factor receptor (LIFR) is a complex that is composed of LIFR-β (or LIFR) subunit and glycoprotein 130. LIFR binds with LIF with high affinity, as a result of which various intracellular signaling pathways are activated. This article reviews the state and function of LIF and LIFR in the occurrence and metastasis of colorectal cancer, and its potential in the diagnosis and treatment of cancer is also anticipated.
(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.
Qian Ma "Role of LIF and LIFR in colorectal cancer", Proc. SPIE 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023), 1292406 (8 January 2024); https://doi.org/10.1117/12.3012845
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Colorectal cancer

Laser induced fluorescence

Cancer

Tumors

Tissues

Proteins

Stem cells

Back to Top